类治疗改善了心力衰竭的动物的心脏功能和结构:系统性审查和元分析
Tingting Lv1, Chunyan Liu2, Mengfei Ye3
1Department of General Practice, Shaoxing People's Hospital, Shaoxing, PR China; Department of Pharmacology, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, PR China.
Nutrition research (New York, N.Y.)
|April 19, 2025
概括
类治疗显著改善了心脏功能和心脏衰竭 (HF) 的动物的结构. 然而,它对健康的动物没有好处,这表明对HF的潜在治疗应用.
科学领域:
- 心血管研究研究心血管研究
- 代谢科学 代谢科学
- 动物模型 动物模型
背景情况:
- 心力衰竭 (HF) 是一种复杂的疾病,具有显著的发病率和死亡率.
- 目前对HF的治疗策略存在局限性.
- 代谢干预,如类疗法,正在被探索作为新的治疗选择.
研究的目的:
- 在动物心力衰竭模型中量化评估干预对心脏功能和结构的影响.
- 为了调查子干预是否可以增强心脏功能和结构在HF.
主要方法:
- 对24项动物研究进行了系统的元分析.
- 研究通过搜索PubMed,Cochrane图书馆和Embase数据库来确定研究.
- 类药物治疗包括性饮食,类,中链甘油三和β-基酸盐.
主要成果:
- 子治疗显著改善了HF动物的左心室射出分数 (SMD: 1.31) 和心脏输出 (SMD: 0.70).
- 它还改善了心肌缩 (SMD: -1.95),纤维化 (SMD: -0.87) 和心室重塑.
- 干预在非HF动物中恶化了心肌纤维化,并且对其心脏功能没有显著影响.
结论:
- 类疗法在心力衰竭的动物中显示出对心脏缩功能和心脏结构的显著益处.
- 基干预在非高频动物中没有产生积极影响.
- 类疗法可能是心力衰竭患者有前途的治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
405
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
405
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305